Daniel Stein

Dr. Stein, a board-certified neurologist, completed his residency at the Cleveland Clinic Foundation and a fellowship in Immunology of Neuromuscular Disease at the prestigious National Institute of Health. He has more than 30 years of experience practicing neurology and has treated over 5,300 patients with cannabis medicine. Dr. Stein is an assistant professor at Florida State University College of Medicine and is a member of the American Journal of Endocannabinoid Medicine editorial board. In addition to providing education to healthcare professionals in the U.S., he has presented lectures on cannabis medicine in South Africa, the UK and Peru. Recent articles include:
1. Dell DD & Stein DS (2021). Exploring the use of medical marijuana for supportive care of oncology patients. J Adv Pract Oncol, 12(2): 188-201.
2. Stein DS. (2020). Ask the Expert: How Does Medical Cannabis help Parkinson’s Disease Patients? CRXMAG Fall Edition;2(4) 14-15.
3. Stein DS (2020). Low levels of endocannabinoids found in children with Autism (A commentary on Aran et al. Lower circulating endocannabinoid levels in children with autism spectrum disorder: Mol Autism. 2019; 10:2. American Journal of Endocannabinoid Medicine, 1(1), 52-53.
Dr. Stein has used his medical training in neurology to assist patients in their journey to greater health and well-being.